Volume 22, Issue 7, Pages (July 2015)

Slides:



Advertisements
Similar presentations
Darren M Brown, Erkki Ruoslahti  Cancer Cell 
Advertisements

Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Michael T. Jacobsen, Michael Fairhead, Per Fogelstrand, Mark Howarth 
Volume 19, Issue 2, Pages (February 2012)
Structure of the Human Telomerase RNA Pseudoknot Reveals Conserved Tertiary Interactions Essential for Function  Carla A. Theimer, Craig A. Blois, Juli.
Volume 21, Issue 2, Pages (February 2014)
Glen S. Cho, Jack W. Szostak  Chemistry & Biology 
Structure of the Human Telomerase RNA Pseudoknot Reveals Conserved Tertiary Interactions Essential for Function  Carla A. Theimer, Craig A. Blois, Juli.
Volume 27, Issue 22, Pages e4 (November 2017)
Volume 47, Issue 1, Pages (July 2012)
Volume 25, Issue 3, Pages (March 2017)
Complex Energy Landscape of a Giant Repeat Protein
Biofilm Inhibitors that Target Amyloid Proteins
Sherilyn Grill, Valerie M. Tesmer, Jayakrishnan Nandakumar 
Volume 19, Issue 7, Pages (July 2012)
Volume 21, Issue 2, Pages (February 2014)
Fuqing Wu, David J. Menn, Xiao Wang  Chemistry & Biology 
Volume 128, Issue 3, Pages (February 2007)
Matthew Levy, Andrew D. Ellington  Chemistry & Biology 
Quantum Dot-Mediated Detection of γ-Aminobutyric Acid Binding Sites on the Surface of Living Pollen Protoplasts in Tobacco  Guanghui Yu, Jiangong Liang,
Volume 14, Issue 10, Pages (October 2007)
Conversion of Red Fluorescent Protein into a Bright Blue Probe
Raluca Ostafe, Radivoje Prodanovic, Jovana Nazor, Rainer Fischer 
Volume 23, Issue 10, Pages (October 2016)
Adaptive Assembly: Maximizing the Potential of a Given Functional Peptide with a Tailor-Made Protein Scaffold  Hideki Watanabe, Shinya Honda  Chemistry.
Functional Dissection of sRNA Translational Regulators by Nonhomologous Random Recombination and In Vivo Selection  Jane M. Liu, Joshua A. Bittker, Maria.
Volume 22, Issue 1, Pages (January 2005)
Structure-Guided Design of Fluorescent S-Adenosylmethionine Analogs for a High- Throughput Screen to Target SAM-I Riboswitch RNAs  Scott F. Hickey, Ming C.
Volume 14, Issue 10, Pages (October 2007)
Coiled Coils Direct Assembly of a Cold-Activated TRP Channel
Volume 22, Issue 3, Pages (March 2015)
Volume 16, Issue 4, Pages (April 2009)
A Solution to Limited Genomic Capacity: Using Adaptable Binding Surfaces to Assemble the Functional HIV Rev Oligomer on RNA  Matthew D. Daugherty, Iván.
Beena Krishnan, Lila M. Gierasch  Chemistry & Biology 
Darren M Brown, Erkki Ruoslahti  Cancer Cell 
Mitochondria-Penetrating Peptides
Volume 13, Issue 5, Pages (May 2006)
Johnson Cheung, Michael E.P. Murphy, David E. Heinrichs 
Volume 19, Issue 7, Pages (July 2012)
Volume 20, Issue 2, Pages (February 2013)
Volume 18, Issue 8, Pages (August 2010)
Michael T. Jacobsen, Michael Fairhead, Per Fogelstrand, Mark Howarth 
Volume 26, Issue 2, Pages e4 (February 2018)
Combining Mutational Signatures, Clonal Fitness, and Drug Affinity to Define Drug- Specific Resistance Mutations in Cancer  Teresa Kaserer, Julian Blagg 
Volume 15, Issue 1, Pages 5-11 (January 2008)
Designing Photoswitchable Peptides Using the AsLOV2 Domain
Volume 22, Issue 1, Pages (January 2015)
Kevin M. Marks, Michael Rosinov, Garry P. Nolan  Chemistry & Biology 
Volume 122, Issue 2, Pages (July 2005)
RNA Quadruplex-Based Modulation of Gene Expression
Volume 20, Issue 2, Pages (February 2013)
Volume 15, Issue 12, Pages (December 2008)
Structural Basis for Specific Recognition of Reelin by Its Receptors
Inhibitor Mediated Protein Degradation
Volume 20, Issue 8, Pages (August 2013)
Volume 21, Issue 8, Pages (August 2014)
Volume 29, Issue 3, Pages (March 2016)
Volume 22, Issue 11, Pages (November 2015)
Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Volume 19, Issue 7, Pages (July 2011)
Structural Insight into BLM Recognition by TopBP1
Analyzing Fission Yeast Multidrug Resistance Mechanisms to Develop a Genetically Tractable Model System for Chemical Biology  Shigehiro A. Kawashima,
Volume 21, Issue 10, Pages (October 2014)
Discovery of Antagonist Peptides against Bacterial Helicase-Primase Interaction in B. stearothermophilus by Reverse Yeast Three-Hybrid  Laurence Gardiner,
Volume 12, Issue 9, Pages (September 2005)
Uma B. Karadge, Minja Gosto, Matthew L. Nicotra  Current Biology 
Volume 18, Issue 3, Pages (March 2011)
Volume 27, Issue 7, Pages e5 (July 2019)
Basis of Mutual Domain Inhibition in a Bacterial Response Regulator
Binding Specificity of Retinal Analogs to Photoactivated Visual Pigments Suggest Mechanism for Fine-Tuning GPCR-Ligand Interactions  Sundaramoorthy Srinivasan,
Presentation transcript:

Volume 22, Issue 7, Pages 946-956 (July 2015) A 45-Amino-Acid Scaffold Mined from the PDB for High-Affinity Ligand Engineering  Max A. Kruziki, Sumit Bhatnagar, Daniel R. Woldring, Vandon T. Duong, Benjamin J. Hackel  Chemistry & Biology  Volume 22, Issue 7, Pages 946-956 (July 2015) DOI: 10.1016/j.chembiol.2015.06.012 Copyright © 2015 Elsevier Ltd Terms and Conditions

Chemistry & Biology 2015 22, 946-956DOI: (10. 1016/j. chembiol. 2015 Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 1 Summary of Information for Top Potential Scaffolds (A) Structure and proposed paratope surface (red) of top five scoring scaffolds. Images created in PyMol. (B) PDB ID, amino acid length, % β strand, and % α helix are all from the PDB. Loop residues are identified as residues between secondary structural elements. Loop accessible surface area (ASA) is calculated using GetArea after mutating loop residues to serines within PyMol. ΔΔGf,mut was calculated for random loop mutants using Eris. Fibronectin (1ttg) and Affibody (2b88) are included for comparison. See also Table S1 for commonly used scaffolds. Chemistry & Biology 2015 22, 946-956DOI: (10.1016/j.chembiol.2015.06.012) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 2 Solution Structure of Gp2 Diversified amino acids are highlighted in red and underlined in sequence. The N- and C-terminal tails removed to create the Gp2 scaffold are highlighted in blue. An I17V (boldface in sequence) mutation was added based on prevalence in homologous protein sequences. Images created in Macpymol (PDB: 2WNM). Chemistry & Biology 2015 22, 946-956DOI: (10.1016/j.chembiol.2015.06.012) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 3 Binding Characterization (A) Yeast displaying GαGIgG2.2.1 (red circles), GαRIgG3.2.3 (green triangles), and GαLysA0.3.3 (gray squares) were incubated with the indicated concentrations of biotinylated target. Binding was detected by streptavidin-fluorophore via flow cytometry. Titration indicates equilibrium dissociation constants of 0.2 ± 0.1, 2.3 ± 1.4, and 0.9 ± 0.7 nM. (B) Yeasts were incubated with 1 μM goat IgG (G), lysozyme (L), rabbit IgG (R), or transferrin (T). Binding was detected by streptavidin-fluorophore via flow cytometry. Data are normalized to signal of intended target for each yeast strain. Error bars represent ±SD of n = 3 samples. See Figure S3 for full collection of affinity titration curves. Chemistry & Biology 2015 22, 946-956DOI: (10.1016/j.chembiol.2015.06.012) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 4 Soluble Gp2 Characterization (A and B) Purified Gp2 clones (blue, wild-type; red, GαGIgG2.2.1; green, GαRIgG3.2.3) were analyzed by circular dichroism spectroscopy. (A) Molar ellipticity (θ) was measured at indicated wavelengths before (solid lines) and after (dashed lines) thermal denaturation. (B) Molar ellipticity was monitored at 218 nm upon heating from 25°C to 98°C at 1°C per minute. (C) Biotinylated IgG (2 nM goat or 4 nM rabbit as appropriate) was incubated with the indicated concentration of purified Gp2 and used to label yeast displaying the corresponding Gp2 clone. IgG binding was measured by streptavidin-fluorophore via flow cytometry. (D) Purified GαGIgG2.2.1 was subjected to various treatments prior to use in the competitive binding assay (as in C). Unblocked is a control without Gp2 competition. Pre-HPLC uses competition by GαGIgG2.2.1 that was purified on a metal affinity column. Post-HPLC uses competition by GαGIgG2.2.1 purified by metal affinity chromatography and reverse-phase high-performance liquid chromatography and lyophilization. Post-heat uses competition by GαGIgG2.2.1 purified as in Post-HPLC along with heating to 98°C and cooling back to 22°C. Error bars are ±SD on n = 2 samples. See Figure S2 for GαLysA0.3.3. Chemistry & Biology 2015 22, 946-956DOI: (10.1016/j.chembiol.2015.06.012) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 5 GαEGFR2.2.3 Affinity and Stability (A) Population of yeast displaying Gp2 incubated with 50 nM EGFR and anti-c-MYC antibody. Secondary fluorophores detect binding of EGFR and antibody. Spread of double-positive cells suggests moderate diversity of EGFR-binding Gp2 molecules. GαEGFR2.2.3 was collected from top 1% of double positives. (B) A431 cells were incubated with indicated amount of purified Gp2. Binding was detected by anti-His6 fluorophore. Titration indicates an equilibrium dissociation constant of 18 ± 8 nM. (C) Molar ellipticity was monitored at 218 nm upon heating from 25°C to 98°C at 1°C per minute. Molar ellipticity before (solid) and after (dashed) thermal denaturation is inset. (D) Fluorescence microscopy of adhered cancer cell lines, incubated with 100 nM Gp2 protein and detected by anti-His6-fluorescein. A431 cells labeled with GαEGFR2.2.3 (left column) show localization to cell surface. A431 cells labeled with Gp2 WT (middle column) and MCF7 cells labeled with GαEGFR2.2.3 (right column) show very little detectable binding. Scale bar represents 200 μm. (E) A431 cells preincubated with PBS or 1 μM GαEGFR2.2.3 and labeled with 200 nM biotinylated GαEGFR2.2.3. Binding detected with streptavidin-fluorophore. (F) Cancer cell lines expressing varying levels of EGFR: MCF7 with 2 × 104 receptors (gray line) (Reilly et al., 2000), MDA-MB-231 with 1 × 105 receptors (red dots) (Reilly et al., 2000), DU145 with 2 × 105 receptors (black dashes) (Malmberg et al., 2011), and A431with 3 × 106 (green dashes) (Spangler et al., 2010) were incubated with 1 μM GαEGFR2.2.3 and detected with anti-His6-fluorescein by flow cytometry. Chemistry & Biology 2015 22, 946-956DOI: (10.1016/j.chembiol.2015.06.012) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 6 Deep Sequencing Comparison of Naive and Binding Populations All sequences were grouped into families and damped. (A) Diversified loop positions (CDR′) are shown at the top, with 9a and 9b, or 36a and 36b, representing loop length diversity positions. Positions with an absolute change of 5% or greater are labeled. All labeled positions have p < 0.001 (n ≥ 96, number of damped sequences). (B) Relative change in amino acid frequency by framework position from the naive library to combined mature populations. Certain mutations are more common than others due to error-prone PCR limitations. Positions where wild-type was conserved (#) or mutated (∗) significantly more often (p < 0.001 for 3% deviation, n ≥ 421) than the mean mutation rate are denoted. (C) Frequency of Gp2 loop length in amino acids. The naive library was designed with equal loop length frequencies, but DNA bias during construction lead to overrepresentation of shorter loops. Mature combines high throughput sequencing from the four binding populations. All have p < 0.001. Error bars are ±SD for n = 4.9 × 104 for naive and n ≥ 477 for mature (number of damped sequences). See also Figure S1. Chemistry & Biology 2015 22, 946-956DOI: (10.1016/j.chembiol.2015.06.012) Copyright © 2015 Elsevier Ltd Terms and Conditions